Aurinia Pharmaceuticals (AUPH) EBT (2018 - 2025)
Historic EBT for Aurinia Pharmaceuticals (AUPH) over the last 9 years, with Q3 2025 value amounting to $32.0 million.
- Aurinia Pharmaceuticals' EBT rose 11585.74% to $32.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.6 million, marking a year-over-year increase of 49541.23%. This contributed to the annual value of $7.4 million for FY2024, which is 10961.42% up from last year.
- As of Q3 2025, Aurinia Pharmaceuticals' EBT stood at $32.0 million, which was up 11585.74% from $22.2 million recorded in Q2 2025.
- In the past 5 years, Aurinia Pharmaceuticals' EBT registered a high of $32.0 million during Q3 2025, and its lowest value of -$50.4 million during Q1 2021.
- In the last 5 years, Aurinia Pharmaceuticals' EBT had a median value of -$13.1 million in 2023 and averaged -$14.6 million.
- Per our database at Business Quant, Aurinia Pharmaceuticals' EBT crashed by 9247.61% in 2021 and then skyrocketed by 139905.28% in 2025.
- Over the past 5 years, Aurinia Pharmaceuticals' EBT (Quarter) stood at -$32.6 million in 2021, then increased by 22.72% to -$25.2 million in 2022, then fell by 4.86% to -$26.4 million in 2023, then skyrocketed by 104.44% to $1.2 million in 2024, then skyrocketed by 2624.81% to $32.0 million in 2025.
- Its last three reported values are $32.0 million in Q3 2025, $22.2 million for Q2 2025, and $24.3 million during Q1 2025.